210 related articles for article (PubMed ID: 1381718)
1. Interleukin-7 is a growth factor for Sézary lymphoma cells.
Dalloul A; Laroche L; Bagot M; Mossalayi MD; Fourcade C; Thacker DJ; Hogge DE; Merle-Béral H; Debré P; Schmitt C
J Clin Invest; 1992 Sep; 90(3):1054-60. PubMed ID: 1381718
[TBL] [Abstract][Full Text] [Related]
2. Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome.
Foss FM; Koc Y; Stetler-Stevenson MA; Nguyen DT; O'Brien MC; Turner R; Sausville EA
J Clin Oncol; 1994 Feb; 12(2):326-35. PubMed ID: 8113839
[TBL] [Abstract][Full Text] [Related]
3. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.
Rappl G; Muche JM; Abken H; Sterry W; Tilgen W; Ugurel S; Reinhold U
J Am Acad Dermatol; 2001 Mar; 44(3):456-61. PubMed ID: 11209115
[TBL] [Abstract][Full Text] [Related]
4. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
5. CD7- T cells represent a subset of normal human blood lymphocytes.
Reinhold U; Abken H; Kukel S; Moll M; Müller R; Oltermann I; Kreysel HW
J Immunol; 1993 Mar; 150(5):2081-9. PubMed ID: 7679701
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 7 is a growth factor for mature human T cells.
Londei M; Verhoef A; Hawrylowicz C; Groves J; De Berardinis P; Feldmann M
Eur J Immunol; 1990 Feb; 20(2):425-8. PubMed ID: 1968841
[TBL] [Abstract][Full Text] [Related]
8. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
[TBL] [Abstract][Full Text] [Related]
9. Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndrome.
Abrams JT; Lessin SR; Ghosh SK; Nowell PC; Ju W; Vonderheid EC; Rook AH; DeFreitas E
J Immunol; 1991 Mar; 146(5):1455-62. PubMed ID: 1847162
[TBL] [Abstract][Full Text] [Related]
10. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
[TBL] [Abstract][Full Text] [Related]
12. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
Thivolet J; Schmitt D; Souteyrand P; Brochier J
Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
[TBL] [Abstract][Full Text] [Related]
13. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
14. Sézary T-cell-activating factor induces functional interleukin 2 receptors on T-cells derived from patients with Sézary syndrome.
Abrams JT; Ghosh SK; DeFreitas E
Cancer Res; 1993 Nov; 53(22):5501-6. PubMed ID: 8221690
[TBL] [Abstract][Full Text] [Related]
15. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
16. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
Tendler CL; Burton JD; Jaffe J; Danielpour D; Charley M; McCoy JP; Pittelkow MR; Waldmann TA
Cancer Res; 1994 Aug; 54(16):4430-5. PubMed ID: 7913876
[TBL] [Abstract][Full Text] [Related]
17. Sezary lineage cells can be induced to proliferate via CD28-mediated costimulation.
McCusker ME; Garifallou M; Bogen SA
J Immunol; 1997 May; 158(10):4984-91. PubMed ID: 9144518
[TBL] [Abstract][Full Text] [Related]
18. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
[TBL] [Abstract][Full Text] [Related]
19. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor.
Yoshino I; Yano T; Murata M; Ishida T; Sugimachi K; Kimura G; Nomoto K
Cancer Res; 1992 Feb; 52(4):775-81. PubMed ID: 1737336
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
